January Issue of the Journal of Cardiac Failure Highlights Prevention, Innovation, and New Strategies to Improve Outcomes Across the Heart Failure Spectrum

A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD implantation are among the highlights of the January issue of the Journal ...
Healio

Q&A: Suicide of patient on LVAD therapy sparks wider mental health discussion

Please provide your email address to receive an email when new articles are posted on . The apparent suicide of a patient with an LVAD sparked discussion about mental health in this population. Healio ...
EurekAlert!

Novel study finds aspirin-free regimen benefits patients with LVAD

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of ...
TCTMD

LVADs Can Be ‘Transformational’ for Elderly HF Patients

Left ventricular assist devices (LVADs), particularly the latest iterations, can greatly increase functional capacity and quality of life for patients with heart failure, more than a decade’s worth of ...
Seeking Alpha

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients

Analysis features the growing need to evolve anticoagulation therapy beyond warfarin to avoid gastrointestinal bleeding, a significant and common complication for left ventricular assist device (LVAD) ...
Healio

FDA OKs updated label allowing aspirin to be dropped after LVAD implant

Please provide your email address to receive an email when new articles are posted on . The FDA approved updated labeling to remove aspirin as part of routine care after implant of Abbott’s fully ...
TCTMD

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

PHILADELPHIA, PA—Adding to a growing list of medical situations in which aspirin appears to do more harm than good, the ARIES HM3 trial has shown that it can safely be dropped from the antithrombotic ...